Your browser doesn't support javascript.
loading
The incidence of acute pancreatitis with GLP-1 receptor agonist therapy in individuals with a known history of pancreatitis.
Lomeli, Laura D; Kodali, Alimitha M; Tsushima, Yumiko; Mehta, Adi E; Pantalone, Kevin M.
Afiliação
  • Lomeli LD; Department of Endocrinology, Cleveland Clinic, Cleveland, OH, USA. Electronic address: lomelil@ccf.org.
  • Kodali AM; Carolina Health Specialist, Myrtle Beach, SC, USA. Electronic address: akodali@carolina-health.com.
  • Tsushima Y; University Hospitals, Cleveland, OH, USA. Electronic address: yumiko.tsushima@uhhospitals.org.
  • Mehta AE; Department of Endocrinology, Cleveland Clinic, Cleveland, OH, USA. Electronic address: mehtaae@ccf.org.
  • Pantalone KM; Department of Endocrinology, Cleveland Clinic, Cleveland, OH, USA. Electronic address: pantalk@ccf.org.
Diabetes Res Clin Pract ; 215: 111806, 2024 Sep.
Article em En | MEDLINE | ID: mdl-39111552
ABSTRACT
Glucagon-like peptide-1 receptor agonists (GLP-1RA) have been reported to increase the risk of acute pancreatitis (AP). This real-world study did not observe a higher frequency of AP with GLP-1RA exposure in adults with T2D and a prior history of AP regardless of etiology.
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Pancreatite / Diabetes Mellitus Tipo 2 / Receptor do Peptídeo Semelhante ao Glucagon 1 Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2024 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Pancreatite / Diabetes Mellitus Tipo 2 / Receptor do Peptídeo Semelhante ao Glucagon 1 Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2024 Tipo de documento: Article